| abstract |
A tyrosinase activity inhibitor and an ameliorant for facial blood flow which each is highly safe; and a medicinal composition, food composition, or cosmetic preparation each containing these as active ingredients. The tyrosinase activity inhibitor and the ameliorant for facial blood flow contain anthocyan obtained through concentration or extraction from a plant material, etc. The medicinal composition, food composition, or cosmetic preparation combines tyrosinase inhibitory activity with the ability to ameliorate facial blood flow. |